Amit Verma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amit Verma has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Kumar
School of Pharmaceutical Sciences, Chhatrapati Shahu Ji Maharaj University
1 shared publication - Ankit Jain
Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani
1 shared publication - Ankita Tiwari
School of Pharmacy, Sharda University, Greater Noida, 201306, Uttar Pradesh, India
1 shared publication Gaytri Gour
1 shared publicationMakhan Lal
Department of Vegetable Science, CCS Haryana Agricultural University, Hisar 125 004, Haryana, India
1 shared publication- Manshi Saxsena
School of Pharmaceutical Sciences, CSJM University, Kanpur, India
1 shared publication
Latest Publications
- 9 May 2026
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 25 (3) , 1-34
Synthesis and Biological Activity of Guanidine Scaffold: A Comprehensive Review
: Derivatives of guanidine are found to be highly informative for their design in antibacterial and anticancer applications, thus positioning them as promising future drug candidates. This study evaluates and synthesizes a diverse group of guanidine derivatives, with a focus on those bearing cyclic aryl and acyl groups. The prepared compounds showed strong antifungal and antibacterial activities with selectivity against Candida albicans and Gram-positive bacteria. The Structure-Activity Relationship analysis showed that substituent groups are important for biological activity, and n-propyl linkages achieved an optimal balance between hemolytic and antibacterial properties. Additionally, the antiproliferative activities of all synthesized compounds (110a-110v) were assessed in Michigan Cancer Foundation-7 (MCF-7) human breast cancer cells. The Structure Activity Relationship study results suggest that planned substitutions can significantly enhance biological activity, offering potential approaches to counter the growing threat of antibiotic resistance.
- 9 May 2026
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 25 (3) , 1-34
Synthesis and Biological Activity of Guanidine Scaffold: A Comprehensive Review
: Derivatives of guanidine are found to be highly informative for their design in antibacterial and anticancer applications, thus positioning them as promising future drug candidates. This study evaluates and synthesizes a diverse group of guanidine derivatives, with a focus on those bearing cyclic aryl and acyl groups. The prepared compounds showed strong antifungal and antibacterial activities with selectivity against Candida albicans and Gram-positive bacteria. The Structure-Activity Relationship analysis showed that substituent groups are important for biological activity, and n-propyl linkages achieved an optimal balance between hemolytic and antibacterial properties. Additionally, the antiproliferative activities of all synthesized compounds (110a-110v) were assessed in Michigan Cancer Foundation-7 (MCF-7) human breast cancer cells. The Structure Activity Relationship study results suggest that planned substitutions can significantly enhance biological activity, offering potential approaches to counter the growing threat of antibiotic resistance.
- Open Access
- 31 October 2022
- Published by EM International in Ecology, Environment and Conservation
- p. S196-S199
Electrical conductivity and accelerating ageing of carrot (Daucus carota) seeds as affected by manure and biofertilizers
- 31 October 2022
- Published by EM International in Ecology, Environment and Conservation
- p. S196-S199
Open AccessElectrical conductivity and accelerating ageing of carrot (Daucus carota) seeds as affected by manure and biofertilizers
- 16 October 2019
- Published by Taylor & Francis
- p. 87-114
Application Potential of Pectin in Drug Delivery
Pectin, a naturally occurring, biodegradable heteropolysaccharides, comprised of (1,4)-linked α-d-galacturonic acid entities and numerous neutral sugars like D-galactose, L-arabinose, and D-xylose, etc., has grabbed the attention of scientists in last few years because of its biodegradability, biocompatibility, and non-toxicity. It has found promising applications in an arena of drug delivery and biomedical field. On the basis of its degree of esterification (DE), it has been classified into two major groups, i.e., low methoxy pectin (LMP) and high methoxyl pectin (HMP). The pectin chains combine to form the three-dimensional frameworks leading to the formation of a gel. The pectin properties can be enhanced and chemically altered to form composites, blends for a multiplicity of pharmaceutical applications. It has been utilized potentially as a polymer for targeted drug delivery. This chapter deals with the application potential of pectin in the development of drug delivery systems.
- 16 October 2019
- Published by Taylor & Francis
- p. 87-114
Application Potential of Pectin in Drug Delivery
Pectin, a naturally occurring, biodegradable heteropolysaccharides, comprised of (1,4)-linked α-d-galacturonic acid entities and numerous neutral sugars like D-galactose, L-arabinose, and D-xylose, etc., has grabbed the attention of scientists in last few years because of its biodegradability, biocompatibility, and non-toxicity. It has found promising applications in an arena of drug delivery and biomedical field. On the basis of its degree of esterification (DE), it has been classified into two major groups, i.e., low methoxy pectin (LMP) and high methoxyl pectin (HMP). The pectin chains combine to form the three-dimensional frameworks leading to the formation of a gel. The pectin properties can be enhanced and chemically altered to form composites, blends for a multiplicity of pharmaceutical applications. It has been utilized potentially as a polymer for targeted drug delivery. This chapter deals with the application potential of pectin in the development of drug delivery systems.